Silevertinib, Black Diamond Therapeutics' lead asset, showed strong Phase 2 results with 60% ORR and 86% CNS ORR. Read why ...

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million ...

The stock has soared more than 220% in three years.

Bronis Coy Phillips, 41, of Mars Hill, will be due in court July 6 in Madison County. He is currently detained in Avery ...

Roughly one in nine Americans aged 65 and older is exposed to a prescription drug combination flagged as a major drug-drug ...

Plus Therapeutics to become Cerenome, to trade under new Nasdaq ticker CNSY on August 3, 2026Affirms 2026 guidance on key milestones Reports ...

MEDP's outlook hinges on whether strong backlog quality and metabolic demand can offset rising cancellations and softer ...

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million people worldwide ...

VANCOUVER, BC / ACCESS Newswire / July 6, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

Tsingke Biotech recently hosted the Oligonucleotide Drug Salon at the Hilton Shanghai Zhangjiang, bringing together experts ...

Lowri avoided meat during the trip to avoid food poisoning. However, she unknowingly ate pork that contained microscopic ...

Biomedical engineers use iPSCs to grow specialized retinal endothelial cells, successfully regenerating damaged eye blood ...